| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT02319837 |
| P6099 | clinical trial phase | phase III clinical trial | Q42824827 |
| P17 | country | Canada | Q16 |
| Spain | Q29 | ||
| United States of America | Q30 | ||
| Finland | Q33 | ||
| Sweden | Q34 | ||
| Denmark | Q35 | ||
| Poland | Q36 | ||
| Italy | Q38 | ||
| Austria | Q40 | ||
| Netherlands | Q55 | ||
| United Kingdom | Q145 | ||
| France | Q142 | ||
| Brazil | Q155 | ||
| Slovakia | Q214 | ||
| Australia | Q408 | ||
| Taiwan | Q865 | ||
| P582 | end time | 2020-07-01 | |
| P2899 | minimum age | 18 | |
| P1132 | number of participants | 1073 | |
| P4844 | research intervention | leuprolide | Q907160 |
| P6153 | research site | University of California, Davis | Q129421 |
| Johns Hopkins University | Q193727 | ||
| Hoffmann-La Roche | Q212646 | ||
| Institut Gustave Roussy | Q266227 | ||
| Université de Montréal | Q392189 | ||
| Emory University | Q621043 | ||
| Samsung Medical Center | Q624119 | ||
| Kaohsiung Medical University | Q700801 | ||
| China Medical University | Q706177 | ||
| Macquarie University | Q741082 | ||
| Aarhus University | Q924265 | ||
| Western University | Q1144262 | ||
| University of Santiago | Q1259453 | ||
| National Taiwan University Hospital | Q1418766 | ||
| University of Alabama at Birmingham | Q1472663 | ||
| Academic Medical Center | Q2487297 | ||
| Antoni van Leeuwenhoekziekenhuis | Q2536586 | ||
| hôpital Foch | Q3145155 | ||
| Kingston General Hospital | Q3145338 | ||
| L'Institut Mutualiste Montsouris | Q3152361 | ||
| Asan Medical Center | Q4803501 | ||
| Box Hill Hospital | Q4951532 | ||
| Cross Cancer Institute | Q5188247 | ||
| Fiona Stanley Hospital | Q5451115 | ||
| Hospital Universitario Puerta del Mar | Q5489257 | ||
| Hospital Universitario 12 de Octubre | Q5902531 | ||
| Northwestern Memorial Hospital | Q7060339 | ||
| Royal Adelaide Hospital | Q7373582 | ||
| Seoul National University Bundang Hospital | Q7451677 | ||
| Westmead Hospital | Q7989074 | ||
| Hospital del Mar | Q9004969 | ||
| Gachon University Gil Hospital | Q12582491 | ||
| Taichung Veterans General Hospital | Q15901822 | ||
| Beatson Institute for Cancer Research | Q25188472 | ||
| Calvary Mater Newcastle Hospital | Q30254214 | ||
| Carolina Urologic Research Center | Q30269511 | ||
| Clinical Research Solutions | Q30269726 | ||
| Duke University Medical Center | Q30279912 | ||
| Austin Health | Q50379732 | ||
| P580 | start time | 2014-12-01 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | A PHASE 3, RANDOMIZED, EFFICACY AND SAFETY STUDY OF ENZALUTAMIDE PLUS LEUPROLIDE, ENZALUTAMIDE MONOTHERAPY, AND PLACEBO PLUS LEUPROLIDE IN MEN WITH HIGH-RISK NONMETASTATIC PROSTATE CANCER PROGRESSING AFTER DEFINITIVE THERAPY |
Search more.